Client A pharmaceutical company. Background The client is interested in using CBD (cannabidiol), the major non-psychoactive component of cannabis, in a breath-operated medical inhaler device. CBD has been associated with a range of therapeutic benefits, but the current knowledge about its toxicity is something that…
- Home
- About
- Industries
- Government departments and international agencies
- Extractables and Leachables
- E-cigarettes and other Nicotine Delivery Devices
- REACH Regulation and REACH Compliance
- Pharmaceutical Product Toxicological Support
- Medical devices
- Food and Food-contact
- Biocides
- Consumer Products Safety Assessment
- Cosmetics
- Plant Protection Products
- Animal feed and Veterinary products
- Areas of Expertise
- Chemical Hazard and Risk Assessments
- Threshold of Toxicological Concern (TTC)
- Mode of Action (MoA)
- (Q)SAR
- Health Criteria Values (HCV)
- Exposure Modelling
- Benchmark dose modelling (BMDL)
- Classification and Labelling
- TK assessments
- Read-across approach
- Literature searching
- Nanomaterials
- Environmental hazard and risk assessment
- Services
- Publications
- Data Privacy